142 related articles for article (PubMed ID: 34415811)
1. A Serum Level of Squamous Cell Carcinoma Antigen as a Real-Time Biomarker of Atopic Dermatitis.
Shimomura M; Okura Y; Takahashi Y; Kobayashi I
Pediatr Allergy Immunol Pulmonol; 2021 Sep; 34(3):102-105. PubMed ID: 34415811
[No Abstract] [Full Text] [Related]
2. Serum squamous cell carcinoma antigen (SCCA)-2 correlates with clinical severity of pediatric atopic dermatitis in Ishigaki cohort.
Takeuchi S; Furusyo N; Ono J; Azuma Y; Takemura M; Esaki H; Yamamura K; Mitamura Y; Tsuji G; Kiyomatsu-Oda M; Hayashi J; Izuhara K; Furue M
J Dermatol Sci; 2019 Aug; 95(2):70-75. PubMed ID: 31378660
[TBL] [Abstract][Full Text] [Related]
3. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis.
Mitsuishi K; Nakamura T; Sakata Y; Yuyama N; Arima K; Sugita Y; Suto H; Izuhara K; Ogawa H
Clin Exp Allergy; 2005 Oct; 35(10):1327-33. PubMed ID: 16238792
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of squamous cell carcinoma antigens 1 and 2 reflect disease severity and clinical type of atopic dermatitis in adult patients.
Okawa T; Yamaguchi Y; Kou K; Ono J; Azuma Y; Komitsu N; Inoue Y; Kohno M; Matsukura S; Kambara T; Ohta S; Izuhara K; Aihara M
Allergol Int; 2018 Jan; 67(1):124-130. PubMed ID: 28734739
[TBL] [Abstract][Full Text] [Related]
5. [BIOMARKER FOR ATOPIC DERMATITIS IN CHILDREN:FOCUSING ON TARC AND NOVEL SCCA2].
Fujisawa T
Arerugi; 2018; 67(8):981-986. PubMed ID: 30249957
[No Abstract] [Full Text] [Related]
6. Differences in Thymus and Activation-Regulated Chemokine and Squamous Cell Carcinoma Antigen 2 Levels in Food Protein-Induced Enterocolitis Syndrome and Atopic Dermatitis.
Makita E; Sugawara D; Kuroda S; Itabashi K; Hirakubo Y; Nonaka K; Ichihashi K
Int Arch Allergy Immunol; 2022; 183(9):967-974. PubMed ID: 35537383
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma antigens are sensitive biomarkers for atopic dermatitis in children and adolescents: a cross-sectional study.
Hirayama J; Fujisawa T; Nagao M; Kuwabara Y; Kainuma K; Azuma Y; Ono J; Ohta S; Hirayama M; Izuhara K
Asia Pac Allergy; 2021 Oct; 11(4):e42. PubMed ID: 34786372
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis.
Ohta S; Shibata R; Nakao Y; Azuma Y; Taniguchi K; Arima K; Suzuki S; Shiraishi H; Iwasaka T; Izuhara K
Ann Clin Biochem; 2012 May; 49(Pt 3):277-84. PubMed ID: 22402915
[TBL] [Abstract][Full Text] [Related]
9. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum level of squamous cell carcinoma antigen with severity of cutaneous psoriasis, assessed using the simplified psoriasis index.
Henry D; Alkhars A; Samimi M; Dufour D; Machet L
Ann Dermatol Venereol; 2024 Mar; 151(1):103246. PubMed ID: 38422600
[TBL] [Abstract][Full Text] [Related]
11. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children.
Leung TF; Ma KC; Hon KL; Lam CW; Wan H; Li CY; Chan IH
Pediatr Allergy Immunol; 2003 Aug; 14(4):296-301. PubMed ID: 12911508
[TBL] [Abstract][Full Text] [Related]
12. Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis.
Hulshof L; Overbeek SA; Wyllie AL; Chu MLJN; Bogaert D; de Jager W; Knippels LMJ; Sanders EAM; van Aalderen WMC; Garssen J; Van't Land B; Sprikkelman AB;
Front Immunol; 2018; 9():630. PubMed ID: 29966024
[TBL] [Abstract][Full Text] [Related]
13. Factors that predict disease severity in atopic dermatitis: The role of serum basal tryptase.
Sahiner UM; Buyuktiryaki B; Gungor HE; Sahiner N; Turasan A; Torun YA; Sekerel BE
Allergy Asthma Proc; 2018 Sep; 39(5):371-376. PubMed ID: 30153887
[TBL] [Abstract][Full Text] [Related]
14. Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity.
Sun Z; Shi X; Wang Y; Zhao Y
Dermatology; 2018; 234(3-4):120-126. PubMed ID: 29870999
[TBL] [Abstract][Full Text] [Related]
15. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
16. Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic Dermatitis.
Holm JG; Hurault G; Agner T; Clausen ML; Kezic S; Tanaka RJ; Thomsen SF
Dermatology; 2021; 237(4):513-520. PubMed ID: 33730733
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma-related antigen in children with acute asthma.
Nishi N; Miyazaki M; Tsuji K; Hitomi T; Muro E; Zaitsu M; Yamamoto S; Inada S; Kobayashi I; Ichimaru T; Izuhara K; Nagumo F; Yuyama N; Hamasaki Y
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):391-7. PubMed ID: 15801252
[TBL] [Abstract][Full Text] [Related]
18. Infantile atopic dermatitis: Serum vitamin D, zinc and TARC levels and their relationship with disease phenotype and severity.
Esenboga S; Cetinkaya PG; Sahiner N; Birben E; Soyer O; Sekerel BE; Sahiner UM
Allergol Immunopathol (Madr); 2021; 49(3):162-168. PubMed ID: 33938202
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
Hon KL; Leung TF; Ma KC; Li AM; Wong Y; Fok TF
Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
[TBL] [Abstract][Full Text] [Related]
20. Can the blood tryptase be an indicator of the severity of atopic dermatitis?
Jaworek AK; Jaworek M; Szafraniec K; Pawlicka A; Wojas-Pelc A
Pol Merkur Lekarski; 2020 Jun; 48(285):162-165. PubMed ID: 32564039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]